EUA
WANTAI SARS-CoV-2 Ab Rapid Test
FDA Emergency Use Authorization · Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. · Mar 12, 2021
Key facts
| Product | WANTAI SARS-CoV-2 Ab Rapid Test |
|---|---|
| Company | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
| Product type | Total Antibody, Lateral Flow |
| Date | Mar 12, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: